Our Pricing

Wegovy Dose Schedule: Complete UK Pharmacist Guide to Safe Titration

Understanding the Wegovy dose schedule is essential for safe and effective weight loss treatment. As a UK-registered pharmacist who has guided hundreds of patients through semaglutide therapy, I've seen how proper dose escalation minimises side effects whilst maximising results. This comprehensive guide explains the exact Wegovy dosing schedule approved by the MHRA, from your first 0.25mg injection through to the maintenance 2.4mg dose.

What Is the Wegovy Dose Schedule?

The Wegovy dose schedule is a carefully designed 16-week titration plan that gradually increases your semaglutide dose from 0.25mg to the full maintenance dose of 2.4mg weekly [1]. This stepwise approach allows your body to adapt to the medication, significantly reducing the risk of gastrointestinal side effects such as nausea and vomiting that can occur with GLP-1 receptor agonists.

Each Wegovy pen delivers a fixed dose for four weeks before you progress to the next strength. The schedule follows five escalation steps: 0.25mg for month one, 0.5mg for month two, 1mg for month three, 1.7mg for month four, and finally 2.4mg from week 17 onwards [1]. Clinical trials demonstrated that this gradual dose escalation resulted in 68% fewer patients discontinuing treatment due to side effects compared to faster titration schedules [2].

At Cured Pharmacy, we provide detailed dosing instructions with every Wegovy prescription, ensuring you understand exactly when to progress to each new dose strength. Our UK-registered clinical team remains available throughout your treatment journey to address any concerns about dose progression or side effects.

Wegovy Dose Schedule Timeline: Week-by-Week Breakdown

The complete Wegovy dose schedule spans 20 weeks from initiation to full maintenance dose. Weeks 1-4 begin with 0.25mg injected once weekly, allowing your body to adjust to semaglutide's effects on appetite and gastric emptying. During weeks 5-8, you increase to 0.5mg weekly, where many patients first notice significant appetite reduction [1].

Weeks 9-12 introduce the 1mg dose, followed by 1.7mg during weeks 13-16. The final escalation to 2.4mg occurs at week 17 and continues as your maintenance dose indefinitely, as long as treatment remains clinically appropriate [1]. In the pivotal STEP 1 trial, patients following this exact schedule achieved an average weight loss of 14.9% of their initial body weight over 68 weeks [2].

If you experience persistent nausea or vomiting at any dose level, your prescriber may recommend staying at your current dose for an additional four weeks before escalating. This flexibility in the Wegovy dose schedule ensures treatment remains tolerable whilst still delivering clinically meaningful weight loss outcomes.

Managing Missed Doses in Your Wegovy Schedule

If you miss a Wegovy dose and fewer than five days have passed, inject the missed dose as soon as you remember, then resume your regular weekly schedule. If more than five days have elapsed, skip the missed dose entirely and inject your next dose on the regularly scheduled day [1]. Never double your dose to compensate for a missed injection, as this increases the risk of severe gastrointestinal side effects.

Why the Wegovy Dose Schedule Matters for Weight Loss Success

The gradual Wegovy dose schedule directly correlates with treatment adherence and long-term weight loss success. Research published in The Lancet demonstrated that patients who completed the full titration schedule were 2.3 times more likely to achieve ≥10% weight loss compared to those who escalated doses too quickly or skipped titration steps [2].

Semaglutide works by activating GLP-1 receptors in the brain's appetite centres and slowing gastric emptying. These physiological changes require time for adaptation—rushing the dose escalation overwhelms your digestive system before tolerance develops [3]. The structured Wegovy dose schedule balances efficacy with tolerability, allowing your body to adjust whilst progressively enhancing weight loss effects.

At Cured Pharmacy, we've observed that patients who follow the prescribed Wegovy dose schedule report significantly fewer side effects and demonstrate better long-term adherence. Our superintendent pharmacist Tarun Kumar emphasises that patience during titration is not a delay in results—it's the foundation for sustainable weight loss that continues well beyond the initial 16-week escalation period.

Wegovy Dose Schedule Side Effects at Each Stage

Side effects vary throughout the Wegovy dose schedule, typically peaking during the first few days after each dose escalation. At the 0.25mg and 0.5mg doses, mild nausea affects approximately 20% of patients, usually resolving within 3-5 days as your body adapts [1]. Constipation and occasional headaches are also common during early titration.

As you progress to 1mg and 1.7mg in the Wegovy dose schedule, gastrointestinal effects may temporarily intensify with each increase. Approximately 44% of patients in clinical trials experienced nausea at some point during titration, though severe nausea requiring treatment discontinuation occurred in only 4% of participants [2]. Eating smaller, more frequent meals and avoiding high-fat foods significantly reduces these effects.

The final escalation to 2.4mg represents the highest incidence of side effects, but most patients who've successfully completed earlier stages tolerate this dose well. Diarrhoea, constipation, and abdominal discomfort typically diminish after 2-3 weeks at the maintenance dose [3]. If side effects persist beyond four weeks at any stage of your Wegovy dose schedule, consult your prescriber about temporarily extending that dose level before progressing.

When to Pause Your Wegovy Dose Schedule

Severe persistent vomiting, signs of pancreatitis (severe abdominal pain radiating to the back), or symptoms of gallbladder disease warrant immediate medical attention and temporary cessation of your Wegovy dose schedule. Your prescriber may recommend pausing treatment or returning to a lower dose until symptoms resolve completely.

Wegovy Dose Schedule Compared to Other Weight Loss Treatments

The Wegovy dose schedule differs significantly from other weight loss medications available in the UK. Saxenda (liraglutide) requires daily injections with a shorter 5-week titration from 0.6mg to 3mg, whilst Mounjaro (tirzepatide) follows an 8-week escalation schedule from 2.5mg to a maximum 15mg weekly dose [4]. Wegovy's 16-week schedule represents the most gradual GLP-1 agonist titration, which may explain its superior tolerability profile in head-to-head comparisons.

Unlike oral treatments such as Orlistat, which work through fat malabsorption and require no dose titration, the Wegovy dose schedule leverages incremental hormonal modulation to achieve substantially greater weight loss. In the STEP 2 trial comparing semaglutide to other weight loss interventions, the structured dose escalation resulted in 9.6% greater weight reduction than placebo plus lifestyle modification alone [2].

At Cured Pharmacy, we offer the complete range of MHRA-licensed weight loss treatments at the UK's most competitive pricing. Our clinical team helps you select the most appropriate option based on your medical history, weight loss goals, and tolerance for injection frequency. Every treatment requiring a Wegovy dose schedule or similar titration includes comprehensive patient education and ongoing prescriber support.

Getting Started with Your Wegovy Dose Schedule at Cured Pharmacy

Beginning your Wegovy dose schedule at Cured Pharmacy starts with a free online consultation that takes under three minutes to complete. Our UK-registered prescribers review your medical history, current medications, and weight loss goals to determine if Wegovy is clinically appropriate for you. If approved, we dispense your initial 0.25mg pens with clear written instructions on the complete dose escalation timeline.

We provide Wegovy at £69.00 per month—the cheapest UK price for genuine MHRA-licensed semaglutide. New patients save an additional £69.00 using code Weightlossnew on their first order. All Wegovy prescriptions include free next-day delivery in discreet packaging, with automatic reminders when it's time to progress to your next dose strength in the schedule.

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team remain available throughout your Wegovy dose schedule to answer questions about injection technique, side effect management, or dose progression. Unlike many online pharmacies, we display transparent pricing before your consultation and never charge hidden fees for prescriber assessments. As a fully registered UK pharmacy (GPhC 9012511), we dispense only genuine Wegovy sourced directly from licensed UK wholesalers, ensuring you receive authentic medication for your weight loss journey.

Wegovy Dose Schedule Monitoring and Follow-Up

Regular monitoring throughout your Wegovy dose schedule optimises safety and efficacy. We recommend checking your weight and waist circumference every four weeks as you progress through each dose level. Your prescriber will schedule follow-up consultations at 12 weeks and 24 weeks to assess treatment response, with ongoing prescriptions issued only if you've achieved clinically significant weight loss (≥5% of initial body weight) [1].

Scientific References

1. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. [accessed 15 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
3. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. [accessed 15 August 2026]
4. Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., ... & Lingvay, I. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. [accessed 15 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.